468 related articles for article (PubMed ID: 23897224)
41. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
42. Effects of nicotine on bone mass and strength in aged female rats.
Akhter MP; Iwaniec UT; Haynatzki GR; Fung YK; Cullen DM; Recker RR
J Orthop Res; 2003 Jan; 21(1):14-9. PubMed ID: 12507575
[TBL] [Abstract][Full Text] [Related]
43. Antiosteoporotic activity of echinacoside in ovariectomized rats.
Li F; Yang X; Yang Y; Guo C; Zhang C; Yang Z; Li P
Phytomedicine; 2013 Apr; 20(6):549-57. PubMed ID: 23428402
[TBL] [Abstract][Full Text] [Related]
44. Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents.
Shahnazari M; Yao W; Wang B; Panganiban B; Ritchie RO; Hagar Y; Lane NE
J Bone Miner Res; 2011 Mar; 26(3):569-81. PubMed ID: 20839286
[TBL] [Abstract][Full Text] [Related]
45. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
46. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
[TBL] [Abstract][Full Text] [Related]
47. Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats.
Wang Y; Huang P; Tang PF; Chan KM; Li G
J Orthop Surg Res; 2011 Jul; 6():34. PubMed ID: 21752290
[TBL] [Abstract][Full Text] [Related]
48. Teriparatide [rhPTH (1-34)], but not strontium ranelate, demonstrated bone anabolic efficacy in mature, osteopenic, ovariectomized rats.
Ma YL; Zeng QQ; Porras LL; Harvey A; Moore TL; Shelbourn TL; Dalsky GP; Wronski TJ; Aguirre JI; Bryant HU; Sato M
Endocrinology; 2011 May; 152(5):1767-78. PubMed ID: 21343258
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of bone structure and quality of ovariectomized rats by microcrack].
Dai RC; Liao EY; Yang C
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):591-6. PubMed ID: 15804068
[TBL] [Abstract][Full Text] [Related]
50. Effects of alendronate on lumbar intervertebral disc degeneration with bone loss in ovariectomized rats.
Song H; Luo Y; Wang W; Li S; Yang K; Dai M; Shen Y; Zhang Y; Zhang L
Spine J; 2017 Jul; 17(7):995-1003. PubMed ID: 28288923
[TBL] [Abstract][Full Text] [Related]
51. Comparison of parathyroid hormone and strontium ranelate in combination with whole-body vibration in a rat model of osteoporosis.
Hoffmann DB; Sehmisch S; Hofmann AM; Eimer C; Komrakova M; Saul D; Wassmann M; Stürmer KM; Tezval M
J Bone Miner Metab; 2017 Jan; 35(1):31-39. PubMed ID: 26825660
[TBL] [Abstract][Full Text] [Related]
52. [Effects of Dioscorea septemloba on the biomechanical and bone histomorphometric parameters of femur in the ovariectomized rats].
Xing GS; Lou JS; Yu SL; Wang ZB; Shi YJ
Zhong Yao Cai; 2008 Feb; 31(2):272-6. PubMed ID: 18619278
[TBL] [Abstract][Full Text] [Related]
53. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC
J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
[TBL] [Abstract][Full Text] [Related]
54. The effects of fructo-oligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats.
Devareddy L; Khalil DA; Korlagunta K; Hooshmand S; Bellmer DD; Arjmandi BH
Menopause; 2006; 13(4):692-9. PubMed ID: 16837891
[TBL] [Abstract][Full Text] [Related]
55. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
Bahar H; Gallacher K; Downall J; Nelson CA; Shomali M; Hattersley G
Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
[TBL] [Abstract][Full Text] [Related]
56. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
Chen HK; Ke HZ; Jee WS; Ma YF; Pirie CM; Simmons HA; Thompson DD
J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
[TBL] [Abstract][Full Text] [Related]
57. Effect of concurrent administration of alendronate sodium and retinol on development of changes in histomorphometric parameters of bones induced by ovariectomy in rats.
Pytlik M; Kaczmarczyk-Sedlak I; Sliwiński L; Janiec W; Rymkiewicz I
Pol J Pharmacol; 2004; 56(5):571-9. PubMed ID: 15591645
[TBL] [Abstract][Full Text] [Related]
58. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
[TBL] [Abstract][Full Text] [Related]
59. Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeys.
Kostenuik PJ; Smith SY; Samadfam R; Jolette J; Zhou L; Ominsky MS
J Bone Miner Res; 2015 Apr; 30(4):657-69. PubMed ID: 25369992
[TBL] [Abstract][Full Text] [Related]
60. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]